Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

✍ Scribed by Rochlitz, C; Lohri, A; Bacchi, M; Schmidt, M; Nagel, S; Fopp, M; Fey, MF; Herrmann, R; Neubauer, A

• Book ID: 110054273
• Publisher: Nature Publishing Group
• Year: 1999
• Tongue: English
• Weight: 105 KB
• Volume: 13
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2401484